A detailed history of Capital Fund Management S.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Fund Management S.A. holds 131,900 shares of ABBV stock, worth $23.7 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
131,900
Previous 387,900 66.0%
Holding current value
$23.7 Million
Previous $66.5 Million 60.85%
% of portfolio
0.07%
Previous 0.2%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $60.9 Million - $68.6 Million
-442,483 Reduced 61.52%
276,712 $42.9 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $51.4 Million - $59.5 Million
385,016 Added 115.21%
719,195 $107 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $44.3 Million - $55.1 Million
334,179 New
334,179 $45 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $2.66 Million - $3.19 Million
-19,234 Reduced 12.99%
128,808 $20.8 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $19.9 Million - $22.8 Million
148,042 New
148,042 $19.9 Billion
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $7.73 Million - $9.78 Million
-71,951 Reduced 45.09%
87,617 $11.9 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $568,920 - $645,810
5,347 Added 3.47%
159,568 $17.2 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $6.84 Million - $7.62 Million
64,973 Added 72.8%
154,221 $17.4 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $4.46 Million - $4.91 Million
43,574 Added 95.4%
89,248 $9.66 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $31.7 Million - $42.5 Million
-432,538 Reduced 90.45%
45,674 $4.48 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $22.4 Million - $34 Million
347,634 Added 266.23%
478,212 $36.4 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $28.9 Million - $36.2 Million
-400,618 Reduced 75.42%
130,578 $11.6 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $6.3 Million - $7.57 Million
-100,000 Reduced 15.84%
531,196 $40.2 Million
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $4.39 Million - $5.61 Million
66,800 Added 11.84%
631,196 $45.9 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $41.3 Million - $48.7 Million
535,969 Added 1885.42%
564,396 $45.5 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $112 Million - $138 Million
-1,439,785 Reduced 98.06%
28,427 $2.62 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $17.8 Million - $19.8 Million
200,000 Added 15.77%
1,468,212 $139 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $78.4 Million - $92.7 Million
873,100 Added 220.98%
1,268,212 $118 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $36.4 Million - $48.7 Million
395,112 New
395,112 $37.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.